DIAGAST

DIAGAST is a specialized company founded in 1988, originating from the Regional Blood Transfusion Center in Lille, France. It focuses on immunohaematology, ensuring safe and compatible blood transfusions worldwide. The company has a strong partnership with the French Blood Service and operates from Parc Eurasanté, a hub for advanced medical research and healthcare. DIAGAST designs, develops, manufactures, and markets a wide range of monoclonal reagents and automated systems for blood grouping and immunohaematology testing. Their offerings include monoclonal reagents for blood typing, automated systems for blood group determination, and safety test kits for hygienic blood grouping. The ABD PAD® system provides quick manual blood grouping results, enhancing efficiency in clinical settings. DIAGAST manages the entire production process, ensuring high quality and cost-effectiveness. The company serves blood transfusion centers, clinical laboratories, and healthcare professionals involved in transfusion medicine. DIAGAST is committed to providing high-performance, safe, and reliable solutions to prevent transfusion errors and protect patient lives.

• Employees 190
• Founded 1988
• Annual Revenue $46000000